211 related articles for article (PubMed ID: 26980046)
21. Tumour budding as a prognostic biomarker in biopsies and resections of neoadjuvant-treated rectal adenocarcinoma.
Aherne S; Donnelly M; Ryan ÉJ; Davey MG; Creavin B; McGrath E; McCarthy A; Geraghty R; Gibbons D; Nagtegaal I; Lugli A; Kirsch R; Martin ST; Winter DC; Sheahan K;
Histopathology; 2024 Apr; ():. PubMed ID: 38629323
[TBL] [Abstract][Full Text] [Related]
22. High tumor budding stratifies breast cancer with metastatic properties.
Salhia B; Trippel M; Pfaltz K; Cihoric N; Grogg A; Lädrach C; Zlobec I; Tapia C
Breast Cancer Res Treat; 2015 Apr; 150(2):363-71. PubMed ID: 25779101
[TBL] [Abstract][Full Text] [Related]
23. Tumour budding is a strong and independent prognostic factor in pancreatic cancer.
Karamitopoulou E; Zlobec I; Born D; Kondi-Pafiti A; Lykoudis P; Mellou A; Gennatas K; Gloor B; Lugli A
Eur J Cancer; 2013 Mar; 49(5):1032-9. PubMed ID: 23177090
[TBL] [Abstract][Full Text] [Related]
24. Tumor Budding and Poorly Differentiated Clusters in Small Intestinal Adenocarcinoma.
Jun SY; Chung JY; Yoon N; Jung ES; Oh YH; Hong SM
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32781596
[TBL] [Abstract][Full Text] [Related]
25. Correlation of S1P1 and ERp29 expression to progression, metastasis, and poor prognosis of gallbladder adenocarcinoma.
Yuan LW; Liu DC; Yang ZL
Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):189-95. PubMed ID: 23558074
[TBL] [Abstract][Full Text] [Related]
26. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.
Glickman JN; Torres C; Wang HH; Turner JR; Shahsafaei A; Richards WG; Sugarbaker DJ; Odze RD
Cancer; 1999 Feb; 85(4):769-78. PubMed ID: 10091753
[TBL] [Abstract][Full Text] [Related]
27. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.
Estrella JS; Hofstetter WL; Correa AM; Swisher SG; Ajani JA; Lee JH; Bhutani MS; Abraham SC; Rashid A; Maru DM
Am J Surg Pathol; 2011 Jul; 35(7):1045-53. PubMed ID: 21602659
[TBL] [Abstract][Full Text] [Related]
28. Management of T1 colorectal cancers after endoscopic treatment based on the risk stratification of lymph node metastasis.
Miyachi H; Kudo SE; Ichimasa K; Hisayuki T; Oikawa H; Matsudaira S; Kouyama Y; Kimura YJ; Misawa M; Mori Y; Ogata N; Kudo T; Kodama K; Hayashi T; Wakamura K; Katagiri A; Baba T; Hidaka E; Ishida F; Kohashi K; Hamatani S
J Gastroenterol Hepatol; 2016 Jun; 31(6):1126-32. PubMed ID: 26641025
[TBL] [Abstract][Full Text] [Related]
29. Arrest of cell proliferation in budding tumor cells ahead of the invading edge of colonic carcinomas. A preliminary report.
Rubio CA
Anticancer Res; 2008; 28(4C):2417-20. PubMed ID: 18751428
[TBL] [Abstract][Full Text] [Related]
30. S100A4 expression is a prognostic indicator in small intestine adenocarcinoma.
Roh J; Knight S; Chung JY; Eo SH; Goggins M; Kim J; Cho H; Yu E; Hong SM
J Clin Pathol; 2014 Mar; 67(3):216-21. PubMed ID: 24062356
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical evaluation of tumor budding for stratifying T1 colorectal cancer: optimal cut-off value and a novel computer-assisted semiautomatic method.
Takamatsu M; Kawachi H; Yamamoto N; Kobayashi M; Toyama Y; Maekawa T; Chino A; Saito S; Ueno M; Takazawa Y; Ishikawa Y
Mod Pathol; 2019 May; 32(5):675-683. PubMed ID: 30552417
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining.
Blank A; Schenker C; Dawson H; Beldi G; Zlobec I; Lugli A
Front Med (Lausanne); 2019; 6():247. PubMed ID: 31737639
[TBL] [Abstract][Full Text] [Related]
33. Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinoma.
Yoon HH; Shi Q; Sukov WR; Lewis MA; Sattler CA; Wiktor AE; Wu TT; Diasio RB; Jenkins RB; Sinicrope FA
J Clin Oncol; 2012 Nov; 30(32):3932-8. PubMed ID: 22987085
[TBL] [Abstract][Full Text] [Related]
34. Tumor budding as a novel predictor of occult metastasis in cT2N0 tongue squamous cell carcinoma.
Sakata J; Yamana K; Yoshida R; Matsuoka Y; Kawahara K; Arita H; Nakashima H; Nagata M; Hirosue A; Kawaguchi S; Gohara S; Nagao Y; Hiraki A; Shinohara M; Toya R; Murakami R; Nakayama H
Hum Pathol; 2018 Jun; 76():1-8. PubMed ID: 29307623
[TBL] [Abstract][Full Text] [Related]
35. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
[TBL] [Abstract][Full Text] [Related]
36. D2-40 in breast cancer: should we detect more vascular emboli?
de Mascarel I; MacGrogan G; Debled M; Sierankowski G; Brouste V; Mathoulin-Pélissier S; Mauriac L
Mod Pathol; 2009 Feb; 22(2):216-22. PubMed ID: 18820667
[TBL] [Abstract][Full Text] [Related]
37. Tumor Budding Is an Objective High-risk Factor Associated With Metastasis and Poor Clinical Prognosis in Cutaneous Squamous Cell Carcinoma Sized <4 cm.
Fujimoto M; Yamamoto Y; Takai T; Fujimoto N; Ogawa K; Yoshikawa T; Matsuzaki I; Takahashi Y; Iwahashi Y; Warigaya K; Kojima F; Jinnin M; Murata SI
Am J Surg Pathol; 2019 Jul; 43(7):975-983. PubMed ID: 31094931
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of her-2 associated with the progression of esophageal cancer patients.
Wang G; Zhang W; Jiang W; Luan L
Hepatogastroenterology; 2013; 60(128):1972-8. PubMed ID: 24719937
[TBL] [Abstract][Full Text] [Related]
39. Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort.
Graham RP; Vierkant RA; Tillmans LS; Wang AH; Laird PW; Weisenberger DJ; Lynch CF; French AJ; Slager SL; Raissian Y; Garcia JJ; Kerr SE; Lee HE; Thibodeau SN; Cerhan JR; Limburg PJ; Smyrk TC
Am J Surg Pathol; 2015 Oct; 39(10):1340-6. PubMed ID: 26200097
[TBL] [Abstract][Full Text] [Related]
40. Cellular Dissociation Grading Based on the Parameters Tumor Budding and Cell Nest Size in Pretherapeutic Biopsy Specimens Allows for Prognostic Patient Stratification in Esophageal Squamous Cell Carcinoma Independent From Clinical Staging.
Jesinghaus M; Brühl F; Steiger K; Klare P; Reiser M; Scheiter A; Konukiewitz B; Kuhn P; Münch S; Quante M; Schmid RM; Wilhelm D; Feith M; Friess H; Combs SE; Saur D; Boxberg M; Weichert W
Am J Surg Pathol; 2019 May; 43(5):618-627. PubMed ID: 30807302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
